Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Shares Outstanding (Weighted Average) (2016 - 2021)

Phio Pharmaceuticals' Shares Outstanding (Weighted Average) history spans 10 years, with the latest figure at $12.6 million for Q3 2021.

  • For Q3 2021, Shares Outstanding (Weighted Average) rose 849.38% year-over-year to $12.6 million; the TTM value through Sep 2021 reached $12.6 million, up 849.38%, while the annual FY2020 figure was $23233.0, 94.96% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $12.6 million in Q3 2021 per PHIO's latest filing, up from $428266.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $21.4 million in Q1 2019 to a low of $23233.0 in Q4 2018.
  • Average Shares Outstanding (Weighted Average) over 5 years is $3.4 million, with a median of $1.4 million recorded in 2017.
  • Peak YoY movement for Shares Outstanding (Weighted Average): plummeted 98.97% in 2018, then soared 1883.42% in 2019.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.3 million in 2017, then tumbled by 98.97% to $23233.0 in 2018, then skyrocketed by 1883.42% to $460809.0 in 2019, then tumbled by 94.96% to $23233.0 in 2020, then skyrocketed by 54105.52% to $12.6 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Shares Outstanding (Weighted Average) are $12.6 million (Q3 2021), $428266.0 (Q2 2021), and $10.7 million (Q1 2021).